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Abstract 
Critically ill patients often present stress-induced 
hyperglycemia and low insulin sensitivity [1]. Recent 
studies have shown that high blood glucose (BG) 
levels are linked to worsened patient outcomes and 
increased mortality [2, 3]. Tight glycemic control 
(TGC) aims at reducing BG levels taking into 
account inter-patient variability, evolving 
physiological patient conditions and minimizing 
hypoglycemic risks. Clinical protocols are used to 
specify insulin and nutrition rates and BG 
measurement time interval during control. This 
research compares different protocols to determine 
the best one to use at the CHU of Liege. 
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1 Method 
We compare three protocols: Glucontrol B, 
Targeted and STAR controllers. Glucontrol B is a 
Belgian protocol following an experimental sliding 
scale and aiming BG to be between 140 and 180 
mg/dL. The BG measurement frequency can also 
vary from 1-4 hours. The Targeted and STAR 
controllers are adaptive, model-based predictive 
controllers designed for Christchurch, NZ with a BG 
target value of 90 mg/dL that specify hourly 
measurement. STAR uses a stochastic model 
accounting for hour-to-hour patient variability. 
Controller performance was tested in virtual trials 
using Glucontrol retrospective clinical data and the 
glucose-insulin model. STAR was adapted to 
Belgian ICU requirements to create STAR-Belgium. 
 
2 Results 
Initial results show better performance for the 
Targeted and STAR controllers. However, they can 
be aggressive increasing the risk of hypoglycemia 
(BG < 40 mg/dL). To improve the STAR controller, 
we allow the nutrition rate to be increased when BG 
is low and no insulin has been given, and also limit 
the insulin rate change per intervention. For better 
comparison, the target is changed to 144 mg/dL 
using 2 hourly measurements when the patient is 
glycemically stable. 
The resulting controller, STAR-Belgium, has the 
lowest percent of hypoglycemic events and provides 
the tightest control around its BG target illustrated 
by the steeper BG CDF in Figure 1 and in Table 1.  
 
Figure 1 - Comparison of BG CDF for Glucontrol B (blue line) 
and STAR-Belgium (green line) controllers, for whole cohort 
% BG Glucontrol B STAR 
STAR-
Belgium 
< 40 mg/dL 0.054 0.062 0.020 
> 180 mg/dL 24.1 6.8 12.9 
in 140-180 mg/dL 42.4 8.5 50.1 
in 120-160 mg/dL 39.33 67.96 58.43 
Table 1 – Virtual trial results: whole cohort statistics 
 
3 Conclusion 
The STAR-Belgium controller is the best clinical 
protocol for TGC in this study. We have shown it is 
highly effective and safe. Pilot trials are currently 
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